Peter Kasper

2.7k citations

42 papers · 1.1k indexed · h-index 19

Impact in

Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment
Chemical Health and Safety top 5%

Papers in ⓘ

Cancer Research 30
- Carcinogens and Genotoxicity Assessment 30
Molecular Biology 14
- DNA Repair Mechanisms 4
- bioluminescence and chemiluminescence research 3

Co-authors: Lutz Müller (9 shared papers)Raffaella Corvi (5 shared papers)David Kirkland (8 shared papers)Günter Speit (3 shared papers)Federica Madia (3 shared papers)Jan van Benthem (3 shared papers)Hans-Jörg Martus (1 shared paper)Stephan Madle (7 shared papers)
Journals: Mutation Research/Genetic Toxicology and Environmental Mutagenesis (14 papers)Mutagenesis (5 papers)Mutation research. Fundamental and molecular mechanisms of mutagenesis (2 papers)Pharmacogenomics (1 paper)Advances in experimental medicine and biology (1 paper)
Partner nations: Germany Switzerland United States

In The Last Decade

Peter Kasper

41 papers receiving 1.0k citations

Peers

Countries citing papers authored by Peter Kasper

Since Specialization

Citations

This map shows the geographic impact of Peter Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kasper more than expected).

Fields of papers citing papers by Peter Kasper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kasper. The network helps show where Peter Kasper may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Kasper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Kasper Line = papers co-authored together Peter Kasper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·David Kirkland, Peter Kasper, Hans-Jörg Martus, Lutz Müller, Jan van Benthem, Federica Madia, Raffaella Corvi	2015	139
2	Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: A follow-up to an ECVAM workshop Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·David Kirkland, Peter Kasper, Lutz Müller, Raffaella Corvi, Günter Speit	2008	139
3	Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Lutz Müller, Peter Kasper	2000	78
4	Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities—Report from an ECVAM workshop Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Stefan Pfuhler, David Kirkland, Peter Kasper, Makoto Hayashi, Philippe Vanparys, Paul L. Carmichael, Stephen D. Dertinger, David A. Eastmond, Azeddine Elhajouji, Cyrille Krul, Andreas Rothfuß, Gabriele Schoening, Andrew J. Smith, Guenter Speit, Claire R Thomas, Jan van Benthem, Raffaella Corvi	2009	76
5	In vitro micronucleus assay with Chinese hamster V79 cells — results of a collaborative study with in situ exposure to 26 chemical substances Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Wilhelm von der Hude, S. Kalweit, Günter Engelhardt, Sinead McKiernan, Peter Kasper, Renate Slacik‐Erben, H.G. Miltenburger, Naveed Honarvar, Rudolf Fahrig, Bernd Görlitz, Silvio Albertini, Stephan Kirchner, Dietmar Utesch, Franziska Pötter-Locher, Helga Stopper, Stephan Madle	2000	74
6	Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·David Kirkland, Errol Zeiger, Federica Madia, Nigel J. Gooderham, Peter Kasper, Anthony Lynch, Takeshi Morita, Gladys Ouédraogo, Juan Manuel Parra Morte, Stefan Pfuhler, Vera Rogiers, Markus Schulz, Véronique Thybaud, Jan van Benthem, Philippe Vanparys, Andrew Worth, Raffaella Corvi	2014	50
7	Critical issues with the in vivo comet assay: A report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT) Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Günter Speit, Hajime Kojima, Brian Burlinson, Andrew Collins, Peter Kasper, Ulla Plappert‐Helbig, Yoshifumi Uno, Marie Vasquez, Carol Beevers, Marlies De Boeck, Patricia A. Escobar, Sachiko Kitamoto, Kamala Pant, Stefan Pfuhler, Jin Tanaka, Dan D. Levy	2014	49
8	Compilation and use of genetic toxicity historical control data Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Makoto Hayashi, Kerry L. Dearfield, Peter Kasper, David Lovell, Hans‐Joerg Martus, Véronique Thybaud	2010	40
9	Evaluation studies on the in vitro rat hepatocyte micronucleus assay Mutation Research/Environmental Mutagenesis and Related Subjects ·Kerstin Müller-Tegethoff, Peter Kasper, Lutz Müller	1995	38
10	Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop Toxicology in Vitro ·Raffaella Corvi, Federica Madia, Kathryn Z. Guyton, Peter Kasper, Ruthann A. Rudel, Annamaria Colacci, Jos Kleinjans, Paul Jennings	2017	36
11	OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based Therapeutics Nucleic Acid Therapeutics ·Carol W. Berman, Scott Barros, Sheila M. Galloway, Peter Kasper, Frederick B. Oleson, Catherine Priestley, Kevin Sweder, Michael Schlosser, Zhanna Sobol	2016	33
12	An assessment of the in vitro hepatocyte micronucleus assay Mutation Research/Environmental Mutagenesis and Related Subjects ·Kerstin Müller, Peter Kasper, Lutz Müller	1993	31
13	Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties Critical Reviews in Toxicology ·Jan Willem van der Laan, Peter Kasper, Beatriz Silva Lima, David R. Jones, Markku Pasanen	2016	28
14	Relevance and follow-up of positive results in in vitro genetic toxicity assays: An ILSI-HESI initiative Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Véronique Thybaud, Marilyn J. Aardema, Daniel A. Casciano, Vicki L. Dellarco, Michelle R. Embry, B. Bhaskar Gollapudi, Makoto Hayashi, Michael P. Holsapple, David Jacobson‐Kram, Peter Kasper, James T. MacGregor, Robert W. Rees	2007	27
15	Application of the in vitro rat hepatocyte micronucleus assay in genetic toxicology testing Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Kerstin Müller-Tegethoff, Birgit Kersten, Peter Kasper, Lutz Müller	1997	26
16	A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens Mutagenesis ·Andreas Zeller, Stefan Pfuhler, Silvio Albertini, Frank Bringezu, Andreas Czich, Yasmin Dietz, Rolf Fautz, Nicola J. Hewitt, Annette Kirst, Peter Kasper	2018	25
17	The clastogenic potential in vitro of pyrrolizidine alkaloids employing hepatocyte metabolism Mutation Research Letters ·Lutz Müller, Peter Kasper, Gabriele Kaufmann	1992	24
18	Strategy for genotoxicity testing and stratification of genotoxicity test results—report on initial activities of the IWGT Expert Group Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Lutz Müller, David H. Blakey, Kerry L. Dearfield, Sheila M. Galloway, Peggy J. Guzzie, Makoto Hayashi, Peter Kasper, David Kirkland, James T. MacGregor, James M. Parry, Leonard M. Schechtman, Andrew M. Smith, Noriho Tanaka, David Tweats, Hiroshi Yamasaki	2003	24
19	Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals Advances in experimental medicine and biology ·Sonja Beken, Peter Kasper, Jan‐Willem van der Laan	2016	23
20	Photochemical genotoxicity and photochemical carcinogenesis — Two sides of a Coin? Toxicology Letters ·Lutz Müller, Peter Kasper, Birgit Kersten, Juan Zhang	1998	18

About Peter Kasper

Peter Kasper is a scholar working on Cancer Research, Molecular Biology, Small Animals, Health, Toxicology and Mutagenesis and Plant Science, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (30 papers), Animal testing and alternatives (12 papers), Effects and risks of endocrine disrupting chemicals (11 papers), Genetically Modified Organisms Research (8 papers), Computational Drug Discovery Methods (5 papers), Immunotoxicology and immune responses (5 papers), DNA Repair Mechanisms (4 papers) and bioluminescence and chemiluminescence research (3 papers). The work is most often cited by research in Cancer Research (714 citations), Chemical Health and Safety (22 citations), Health, Toxicology and Mutagenesis (390 citations), Small Animals (189 citations) and Plant Science (299 citations). Peter Kasper has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Lutz Müller, Raffaella Corvi, David Kirkland, Günter Speit, Federica Madia, Jan van Benthem, Hans-Jörg Martus, Stephan Madle, Makoto Hayashi and Véronique Thybaud. Their work appears in journals such as Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Mutagenesis, Mutation research. Fundamental and molecular mechanisms of mutagenesis, Pharmacogenomics and Advances in experimental medicine and biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact